Citation Impact
Citing Papers
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88
2011
Membrane Vesicles Are Immunogenic Facsimiles of Salmonella typhimurium That Potently Activate Dendritic Cells, Prime B and T Cell Responses, and Stimulate Protective Immunity In Vivo
2007
BIGSdb: Scalable analysis of bacterial genome variation at the population level
2010 Standout
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance
2014 Standout
Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin
2004 StandoutNobel
Serogroup B meningococcal vaccines—an unfinished story
2010
Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis
2010
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Immune modulation by bacterial outer membrane vesicles
2015
A guide to vaccinology: from basic principles to new developments
2020
The Structures of Four Macrolide Antibiotics Bound to the Large Ribosomal Subunit
2002 StandoutNobel
Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?
2018 StandoutNobel
Molecular typing of meningococci: recommendations for target choice and nomenclature
2006
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
2004 Standout
A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Protection against Lethal Sepsis
2014
From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak
2011
Biogenesis of bacterial membrane vesicles
2009
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Bacteremic Pneumonia Due to Multidrug-Resistant Pneumococci in 3 Patients Treated Unsuccessfully with Azithromycin and Successfully with Levofloxacin
2000
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
2009
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Structure-based antigen design: a strategy for next generation vaccines
2008
Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale
2013
Outer membrane vesicles from group B Neisseria meningitidis Δgna33 mutant: Proteomic and immunological comparison with detergent‐derived outer membrane vesicles
2006
Antimicrobial Use and Colonization with Erythromycin‐ResistantStreptococcus pneumoniaein Greece during the First 2 Years of Life
2000
Selective Sorting of Cargo Proteins into Bacterial Membrane Vesicles
2010
Meningococcal surrogates of protection?serum bactericidal antibody activity
2005
Regulation of immune responses by extracellular vesicles
2014 Standout
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
2010 StandoutNobel
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Haemophilus influenzae Type b Vaccine Failure in Children Is Associated with Inadequate Production of High-Quality Antibody
2007
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
2013
Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
2010
Exosomes: Therapy delivery tools and biomarkers of diseases
2017
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
2011
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
STREPTOCOCCUS PNEUMONIAE IN COMMUNITY-AQUIRED PNEUMONIA
2001
Bacterial Outer Membrane Vesicles and Vaccine Applications
2014
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Treatment of drug-resistant pneumococcal pneumonia
2002
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
Mutation in 23S rRNA Responsible for Resistance to 16-Membered Macrolides and Streptogramins in Streptococcus pneumoniae
2001
Proteomic Characterization and Functional Analysis of Outer Membrane Vesicles of Francisella novicida Suggests Possible Role in Virulence and Use as a Vaccine
2010
Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria
2014
Chemical parameters influencing fine-tuning in the binding of macrolide antibiotics to the ribosomal tunnel
2007 StandoutNobel
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
2010
Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
2010
A Two-Component Regulatory System Impacts Extracellular Membrane-Derived Vesicle Production in Group A Streptococcus
2016 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Variation of the factor H-binding protein of Neisseria meningitidis
2009
Structural basis for cross-resistance to ribosomal PTC antibiotics
2008 StandoutNobel
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
2010 Standout
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Proteomic Analysis and Immunogenicity of Mannheimia haemolytica Vesicles
2012
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Biogenesis of Outer Membrane Vesicles in Serratia marcescens Is Thermoregulated and Can Be Induced by Activation of the Rcs Phosphorelay System
2012
Multilocus Sequence Typing of Bacteria
2006
Correlates of Protection Induced by Vaccination
2010 Standout
Mycobacterial Membrane Vesicles Administered Systemically in Mice Induce a Protective Immune Response to Surface Compartments of Mycobacterium tuberculosis
2014
Works of Philipp Oster being referenced
The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans
2011
Mucosal Immunity in Healthy Adults after Parenteral Vaccination with Outer‐Membrane Vesicles fromNeisseria meningitidisSerogroup B
2008
Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease
2007
From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease
2005
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
2013
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
2009
Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children
2002
Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine
2009
New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine in Children Aged 16–24 Months
2007
The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease
2005
Post-Marketing Safety Monitoring of a New Group B Meningococcal Vaccine in New Zealand, 2004-2006
2007
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand
2007
MeNZB?: a safe and highly immunogenic tailor-made vaccine against the New Zealand serogroup B disease epidemic strain
2005
The Strategy to Control New Zealand's Epidemic of Group B Meningococcal Disease
2004
The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic.
2004
Characterization of fHbp , nhba ( gna2132 ), nadA , porA , Sequence Type (ST), and Genomic Presence of IS 1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales
2009
Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates
1999
Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines
2007
A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand
2003
Interlaboratory Standardization of the Measurement of Serum Bactericidal Activity by Using Human Complement against Meningococcal Serogroup B, Strain 44/76-SL, before and after Vaccination with the Norwegian MenBvac Outer Membrane Vesicle Vaccine
2005
Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac
2006
2003
The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB
2006
Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine
2006
Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years
2003